A company’s plan to edit the genomes of human embryos worries some researchers — but it might reflect the changing attitudes towards the controversial approach.

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...

Walmart, KPMG and Salesforce are among the companies debuting jobs as they adopt generative AI.

Welcome to the Fierce Biotech Graveyard, a yearly ritual where we remember all the biotechs we lost in 2025. While we're ...

The upcoming EU Biotech Act may be more prominently focused on health. But it will also significantly impact food and food ...

America can either cede the future of biotechnology to our adversaries or summon the vision and resolve to lead it.

Nearly one-third of biotech and pharma professionals are thinking about leaving the U.S. to find biopharma jobs, according to ...

Women leaders are driving success in life sciences but remain underrepresented and undervalued. That needs to change, writes ...

The move reflects ongoing restructuring across the biotech sector as companies adapt to tighter funding and the growing ...

Pharmaceutical company Eli Lilly and Company—or Lilly—announced its plans to build a $6.5 billion manufacturing facility at Generation Park at a news conference Sept. 23.

Bigelow Laboratory for Ocean Sciences is an East Boothbay nonprofit research institute focused on global ocean health.